Posted by Administrator on May 31st, 2006 — in Zyrtec Top News
At Least You’re Not Clay Aiken
Next time you’re hit with hay fever, try to remember that things could be worse. You could be Clay Aiken. The American Idol also-ran is allergic to coffee, chocolate, shellfish, tree nuts, and mushrooms. And mints. Imagine going into anaphylactic shock because you wanted fresh breath. On the other hand, […]
No Comments »
Posted by Administrator on May 31st, 2006 — in Zyrtec Top News
It’s a sure sign of spring, but for the millions who suffer from seasonal allergies, blooming flowers mean something else.
Jane Reed says without allergy medicine, her 4-year-old daughter would be playing inside.
“We do lots of tissues,â€? she said. “We try to give her Zyrtec once a day.” Her husband suffers even worse, but he uses […]
No Comments »
Posted by Administrator on May 9th, 2006 — in Zyrtec Top News
Following Pfizer’s quarterly earnings release, UCB confirms that Zyrtec continues to strengthen its leadership position as the number one most prescribed branded antihistamine in the US in new prescriptions. The US in-market sales of Zyrtec have reached $1,035 million during the past 9 months ending September 30th, 2005 showing a 10% increase against the same […]
No Comments »
Posted by Administrator on May 9th, 2006 — in Zyrtec Top News
Eurand, a specialty pharmaceutical company, today reported the achievement of a major milestone in the development program for its AdvaTab(R) formulation of cetirizine, a leading prescription antihistamine sold in the United States and other markets as Zyrtec(R). AdvaTab Cetirizine is a taste-masked, stabilized formulation that utilizes Eurand’s proprietary Microcaps tastemasking and AdvaTab orally disintegrating tablet […]
No Comments »